Insights

Drug Management

10 Most Expensive Drugs in the US

The Ultra Expensive Drugs. Who’s paying? With the entry of Zolgensma into the market in 2019, the prescription drug market changed almost instantly. T...

Read More
Healthcare | Company News | Pharmacy

RxBenefits Officially Joins Forces with Confidio, Expanding Breadth of Service Offerings to Optimize Pharmacy Benefits

Combined companies create a leading pharmacy benefit optimizer to help benefits consultants and plan sponsors tackle tough challenges including cost, ...

Read More
Healthcare | Drug Pricing | Pharmacy Benefits

Affordable Care Act and Consolidated Appropriations Act Update

On Friday, August 20, 2021, the Departments of Labor, Health and Human Services (HHS) and the Treasury (collectively, the Departments) released update...

Read More
FDA Approvals | Healthcare | COVID-19 | Vaccine | Treatments

FDA Authorized Booster for People With Weakened Immune Systems

Estimate impact of high-risk COVID population Background As expected, on August 12, the U.S. Food and Drug Administration (FDA) authorized a booster d...

Read More
Company News

CONFIDIO Ranks No. 880 on the 2021 Inc. 5000 - With a Three-Year Revenue Growth of 553%

Baltimore-based pharmacy benefits consulting firm ranks among the top 5000 fastest-growing companies in the United States.

Read More
Treatments

Digital Therapeutics (DTx)

Digital Therapeutics (DTx) is somewhat of a new term in the healthcare realm, but this is one trend in the industry that is likely to stick around.

Read More
Healthcare | Company News | Pharmacy

RxBenefits Poised to Join Forces with Confidio, Creating A Leading Pharmacy Benefit Optimizer

Combined company will enable the organizations to further simplify increasingly complex and inefficient models for managing pharmacy.

Read More
Company News | Net Economic Value

Charting the Best Path to Pharmacy Benefit Savings

Confidio’s Net Economic Value model provides a navigation system for selecting your PBM

Read More
COVID-19 | Vaccine

COVID Vaccine Update: Understanding Immunity and Potential for Boosters

As of mid June, at least 173.8 million people have received one or both doses of a coronavirus vaccine in the U.S. This includes more than 143.9 milli...

Read More
FDA Approvals

FDA Approves Alzheimer’s Drug: Aduhelm

*Co-Authored By: Brian Maas, RPh Clinical Consultant

Read More
Company News

Confidio Expands Investment in Innovation and Continues to Grow Team

Investing in top talent to develop sustainable and trusted solutions

Read More
Healthcare | Drug Pricing | Drug Management

Important Changes in Healthcare Promoting Drug Price Transparency

At Confidio, we are continuing to monitor the important changes in regulations regarding price transparency. The Federal Government will issue additio...

Read More